By Mill Chart
Last update: Nov 20, 2023
Our stock screener has detected a potential breakout setup on NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO). This breakout pattern is observed when a stock consolidates following a strong upward movement. It's important to note that this pattern is based on technical analysis, and the actual breakout outcome is uncertain. However, it might be worth keeping an eye on NYSE:NVO.
ChartMill employs a sophisticated system to assign a Technical Rating to every stock in its analysis. This rating, which ranges from 0 to 10, is determined by carefully assessing multiple technical indicators and properties.
We assign a technical rating of 9 out of 10 to NVO. This is due to a consistent performance in both the short and longer term time frames. Also compared to the overall market, NVO is showing a nice and steady performance.
Our latest full technical report of NVO contains the most current technical analsysis.
Besides the Technical Rating, ChartMill also assign a Setup Rating to every stock. This setup score also ranges from 0 to 10 and determines to which extend the stock is consolidating. This is achieved by evaluating multiple short term technical indicators. NYSE:NVO currently has a 8 as setup rating:
NVO has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. There is a resistance zone just above the current price starting at 102.14. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 96.29, a Stop Loss order could be placed below this zone.
A breakout opportunity may arise when the stock surpasses the current consolidation zone and reaches new highs. Traders often wait for this breakout before considering buying the stock. To manage risk, a stop loss order could be placed below the consolidation zone to limit potential losses.
Disclaimer: This article is not intended to provide trading advice. It is crucial to conduct your own analysis and consider your own observations and trading style when making investment decisions. The article solely presents technical observations and should not be relied upon as a sole basis for trading.
More breakout setups can be found in our Breakout screener.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
NOVO-NORDISK A/S-SPONS ADR
NYSE:NVO (5/17/2024, 7:17:01 PM)
After market: 131.65 -0.24 (-0.18%)131.89
-1.15 (-0.86%)
The market has flashed a green signal to investors.
Novo Nordisk's stock may look expensive today, but that may not be the case in even a year or two.
Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.
Could Amgen be the next stock to soar due to a GLP-1 drug?
Is NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) suited for quality investing?
AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.
The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.
Back then, the company wasn't very well known to U.S. investors. That's absolutely not the case these days.
This company is serious about maintaining its leadership.
Both of these businesses are finding traction in a pair of major markets.
This mid-cap biopharma may one day be a titan of the industry.
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) is showing decent growth, but is still valued reasonably.